FDA’S Perspectives on Cardiovascular Devices Eric A. ChenSonna M. Patel-RamanMatthew G. Hillebrenner OriginalPaper 10 March 2009 Pages: 143 - 146
Pediatric Cardiac Devices—An FDA Pediatrician’s Perspective of the Challenges and Potential Solutions Francesca Dolcimascolo OriginalPaper 13 March 2009 Pages: 147 - 149
Implantable Device Therapy for the Treatment of Resistant Hypertension Nikhil JoshiJeremy TaylorJohn D. Bisognano OriginalPaper 04 March 2009 Pages: 150 - 153
Physiologic and Pathologic Changes in Patients with Continuous-Flow Ventricular Assist Devices Ranjit JohnAndrew BoyleLeslie Miller OriginalPaper 04 March 2009 Pages: 154 - 158
Ventricular Assist Devices: History, Patient Selection, and Timing of Therapy Daniel G. TangPhilip E. OyerHari R. Mallidi OriginalPaper 19 March 2009 Pages: 159 - 167
Bone-Marrow-Derived Side Population Cells for Myocardial Regeneration Hesham A. SadekCindy M. MartinDaniel J. Garry OriginalPaper 19 March 2009 Pages: 173 - 181
Chronic Treatment with Clenbuterol Modulates Endothelial Progenitor Cells and Circulating Factors in a Murine Model of Cardiomyopathy James E. RiderSean P. PolsterJennifer L. Hall OriginalPaper 27 March 2009 Pages: 182 - 190
A Gene Expression Profile of the Myocardial Response to Clenbuterol Enrique Lara-PezziCesare M. N. TerraccianoPaul J. R. Barton OriginalPaper 13 March 2009 Pages: 191 - 197
Direct Visualization of Cardiac Radiofrequency Ablation Lesions Christian S. EversullBryant LinPaul J. Wang OriginalPaper 17 March 2009 Pages: 198 - 201
Bone Marrow Stem Cells for the Treatment of Ischemic Heart Disease: A Clinical Trial Review Eric FuhTodd J. Brinton OriginalPaper 17 March 2009 Pages: 202 - 218
Pediatric Cardiac Care Consortium: An Instrument for Evidence-Based Clinical Decision Support Lee A. PylesChristine M. HillsJames H. Moller OriginalPaper 12 March 2009 Pages: 219 - 224
